Two Chinese pharma companies, which supplied 5.5 lakh rapid testing kits for Covid-19 to India, said they are ready to cooperate with Indian agencies looking into allegations of poor accuracy of their products. In separate statements, Guongzhou Wondfo Biotech and Livzon Diagnostics said they follow strict quality control of their products, asserting that specified guidelines must be followed in storage of the kits as as well in their usages to get accurate results.
Two Chinese pharma companies, which supplied 5.5 lakh rapid testing kits for Covid-19 to India, said they are ready to cooperate with Indian agencies looking into allegations of poor accuracy of their products. In separate statements, Guongzhou Wondfo Biotech and Livzon Diagnostics said they follow strict quality control of their products, asserting that specified guidelines must be followed in storage of the kits as as well in their usages to get accurate results.
414.jpeg)
228.jpeg)
411.jpeg)
146.jpeg)
66.jpeg)
221.jpeg)
83.jpeg)
